Edwards Balance Sheet Analysis From 2010 to 2024

EW Stock

USD 88.61 0.86 0.98%

Most indicators from Edwards Lifesciences' financial ratios are interrelated and interconnected. However, analyzing financial ratios indicators one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of financial ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Edwards Lifesciences Valuation and Edwards Lifesciences Correlation analysis.

At this time, Edwards Lifesciences' Selling General Administrative is fairly stable compared to the past year. Sales General And Administrative To Revenue is likely to climb to 0.36 in 2024, whereas Issuance Of Capital Stock is likely to drop slightly above 169.1 M in 2024.

Most indicators from Edwards Lifesciences' fundamental ratios are interrelated and interconnected. However, analyzing fundamental ratios indicators one by one will only give a small insight into Edwards Lifesciences Corp current financial condition. On the other hand, looking into the entire matrix of fundamental ratios indicators, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Edwards Lifesciences Valuation and Edwards Lifesciences Correlation analysis.

	2021	2022	2023	2024 (projected)
Gross Profit	4.0B	4.3B	4.6B	4.9B
Total Revenue	5.2B	5.4B	6.0B	6.3B

Gross Profit Total Revenue

Edwards Lifesciences fundamental ratios Correlations

	Total Assets	Other Current Liab	Total Current Liabilities	Total Stockholder Equity	Property Plant And Equipment Net	Retained Earnings	Non Current Assets Total	Non Currrent Assets Other	Cash And Short Term Investments	Net Receivables	Good Will	Common Stock Shares Outstanding	Non Current Liabilities Total	Inventory	Other Current Assets	Other Stockholder Equity	Total Liab	Property Plant And Equipment Gross	Total Current Assets	Short Long Term Debt Total	Other Liab	Net Debt	Accounts Payable	Cash	Other Assets	Long Term Debt
Total Assets		-0.45	0.88	0.99	0.97	0.92	0.99	0.8	0.81	0.97	0.7	-0.91	0.72	0.96	0.98	-0.63	0.76	0.94	0.96	0.48	0.93	-0.68	0.73	0.85	0.81	0.4
Other Current Liab	-0.45		-0.43	-0.48	-0.48	-0.37	-0.46	-0.4	-0.31	-0.41	-0.34	0.32	-0.13	-0.45	-0.45	0.14	-0.23	-0.5	-0.41	-0.14	-0.41	0.31	-0.51	-0.36	-0.42	0.18
Total Current Liabilities	0.88	-0.43		0.82	0.8	0.69	0.87	0.65	0.74	0.85	0.74	-0.8	0.68	0.85	0.82	-0.34	0.81	0.77	0.85	0.61	0.91	-0.47	0.61	0.77	0.64	0.25
Total Stockholder Equity	0.99	-0.48	0.82		0.99	0.95	0.98	0.84	0.75	0.97	0.66	-0.9	0.63	0.97	0.97	-0.69	0.67	0.97	0.94	0.37	0.87	-0.68	0.75	0.79	0.81	0.34
Property Plant And Equipment Net	0.97	-0.48	0.8	0.99		0.93	0.98	0.8	0.71	0.97	0.67	-0.86	0.64	0.96	0.97	-0.66	0.67	0.96	0.91	0.32	0.87	-0.7	0.78	0.77	0.84	0.31
Retained Earnings	0.92	-0.37	0.69	0.95	0.93		0.89	0.93	0.73	0.93	0.45	-0.87	0.52	0.93	0.91	-0.87	0.53	0.96	0.91	0.27	0.73	-0.66	0.58	0.73	0.79	0.35
Non Current Assets Total	0.99	-0.46	0.87	0.98	0.98	0.89		0.77	0.72	0.95	0.76	-0.87	0.7	0.94	0.95	-0.58	0.75	0.92	0.9	0.46	0.92	-0.61	0.8	0.79	0.79	0.36
Non Currrent Assets Other	0.8	-0.4	0.65	0.84	0.8	0.93	0.77		0.61	0.83	0.33	-0.8	0.29	0.88	0.74	-0.86	0.35	0.91	0.81	0.19	0.58	-0.54	0.44	0.62	0.74	0.16
Cash And Short Term Investments	0.81	-0.31	0.74	0.75	0.71	0.73	0.72	0.61		0.76	0.42	-0.83	0.78	0.72	0.84	-0.55	0.75	0.68	0.92	0.63	0.8	-0.69	0.32	0.93	0.63	0.61
Net Receivables	0.97	-0.41	0.85	0.97	0.97	0.93	0.95	0.83	0.76		0.61	-0.88	0.63	0.98	0.95	-0.67	0.68	0.96	0.95	0.32	0.87	-0.75	0.67	0.82	0.79	0.28
Good Will	0.7	-0.34	0.74	0.66	0.67	0.45	0.76	0.33	0.42	0.61		-0.52	0.72	0.63	0.63	-0.04	0.81	0.55	0.56	0.6	0.79	-0.35	0.88	0.59	0.53	0.37
Common Stock Shares Outstanding	-0.91	0.32	-0.8	-0.9	-0.86	-0.87	-0.87	-0.8	-0.83	-0.88	-0.52		-0.59	-0.9	-0.89	0.62	-0.59	-0.88	-0.93	-0.48	-0.83	0.62	-0.52	-0.85	-0.75	-0.46
Non Current Liabilities Total	0.72	-0.13	0.68	0.63	0.64	0.52	0.7	0.29	0.78	0.63	0.72	-0.59		0.57	0.73	-0.27	0.96	0.48	0.72	0.76	0.85	-0.56	0.54	0.82	0.59	0.74
Inventory	0.96	-0.45	0.85	0.97	0.96	0.93	0.94	0.88	0.72	0.98	0.63	-0.9	0.57		0.93	-0.68	0.63	0.98	0.93	0.33	0.85	-0.69	0.69	0.79	0.84	0.26
Other Current Assets	0.98	-0.45	0.82	0.97	0.97	0.91	0.95	0.74	0.84	0.95	0.63	-0.89	0.73	0.93		-0.64	0.74	0.92	0.96	0.41	0.91	-0.75	0.69	0.86	0.81	0.41
Other Stockholder Equity	-0.63	0.14	-0.34	-0.69	-0.66	-0.87	-0.58	-0.86	-0.55	-0.67	-0.04	0.62	-0.27	-0.68	-0.64		-0.22	-0.74	-0.67	-0.05	-0.37	0.51	-0.23	-0.48	-0.64	-0.3
Total Liab	0.76	-0.23	0.81	0.67	0.67	0.53	0.75	0.35	0.75	0.68	0.81	-0.59	0.96	0.63	0.74	-0.22		0.53	0.74	0.78	0.88	-0.5	0.61	0.79	0.58	0.6
Property Plant And Equipment Gross	0.94	-0.5	0.77	0.97	0.96	0.96	0.92	0.91	0.68	0.96	0.55	-0.88	0.48	0.98	0.92	-0.74	0.53		0.91	0.23	0.78	-0.69	0.68	0.74	0.82	0.22
Total Current Assets	0.96	-0.41	0.85	0.94	0.91	0.91	0.9	0.81	0.92	0.95	0.56	-0.93	0.72	0.93	0.96	-0.67	0.74	0.91		0.48	0.89	-0.76	0.55	0.92	0.79	0.44
Short Long Term Debt Total	0.48	-0.14	0.61	0.37	0.32	0.27	0.46	0.19	0.63	0.32	0.6	-0.48	0.76	0.33	0.41	-0.05	0.78	0.23	0.48		0.61	-0.06	0.31	0.61	0.32	0.74
Other Liab	0.93	-0.41	0.91	0.87	0.87	0.73	0.92	0.58	0.8	0.87	0.79	-0.83	0.85	0.85	0.91	-0.37	0.88	0.78	0.89	0.61		-0.67	0.71	0.89	0.8	0.44
Net Debt	-0.68	0.31	-0.47	-0.68	-0.7	-0.66	-0.61	-0.54	-0.69	-0.75	-0.35	0.62	-0.56	-0.69	-0.75	0.51	-0.5	-0.69	-0.76	-0.06	-0.67		-0.44	-0.8	-0.68	-0.26
Accounts Payable	0.73	-0.51	0.61	0.75	0.78	0.58	0.8	0.44	0.32	0.67	0.88	-0.52	0.54	0.69	0.69	-0.23	0.61	0.68	0.55	0.31	0.71	-0.44		0.51	0.62	0.21
Cash	0.85	-0.36	0.77	0.79	0.77	0.73	0.79	0.62	0.93	0.82	0.59	-0.85	0.82	0.79	0.86	-0.48	0.79	0.74	0.92	0.61	0.89	-0.8	0.51		0.75	0.6
Other Assets	0.81	-0.42	0.64	0.81	0.84	0.79	0.79	0.74	0.63	0.79	0.53	-0.75	0.59	0.84	0.81	-0.64	0.58	0.82	0.79	0.32	0.8	-0.68	0.62	0.75		0.31
Long Term Debt	0.4	0.18	0.25	0.34	0.31	0.35	0.36	0.16	0.61	0.28	0.37	-0.46	0.74	0.26	0.41	-0.3	0.6	0.22	0.44	0.74	0.44	-0.26	0.21	0.6	0.31

Click cells to compare fundamentals

Edwards Lifesciences Account Relationship Matchups

Edwards Lifesciences fundamental ratios Accounts

	2019	2020	2021	2022	2023	2024 (projected)
Total Assets	6.5B	7.2B	8.5B	8.3B	9.4B	9.8B
Other Current Liab	6.4M	39.3M	3.9M	311M	15.2M	14.4M
Retained Earnings	3.7B	4.6B	6.1B	7.6B	9.0B	9.4B
Net Receivables	599.1M	602.8M	664.9M	699.1M	836.9M	878.7M
Good Will	1.2B	1.2B	1.2B	1.2B	1.3B	688.6M
Inventory	640.9M	802.3M	726.7M	875.5M	1.2B	1.2B
Other Current Assets	168M	208.2M	237.1M	195.9M	239.3M	251.3M
Total Liab	2.3B	2.7B	2.7B	2.5B	2.6B	1.4B
Total Current Assets	3.0B	3.1B	3.2B	3.1B	4.0B	4.2B
Other Liab	784.1M	1.1B	969.6M	797.6M	917.2M	963.1M
Net Debt	(500.3M)	(488.3M)	(172.5M)	(77.7M)	(449.1M)	(426.6M)
Accounts Payable	180.4M	196.5M	204.5M	201.9M	201.4M	139.5M
Cash	1.2B	1.2B	862.8M	769M	1.1B	1.2B
Other Assets	274M	1.2B	357.5M	783.1M	900.6M	945.6M
Long Term Debt	594.4M	595M	595.7M	596.3M	597M	425.6M
Short Term Debt	598M	0.0	25.5M	27.2M	24.9M	23.7M
Intangible Assets	336.5M	331.4M	323.6M	285.2M	428.4M	449.8M
Common Stock	218.1M	636.4M	642M	646.3M	650.5M	683.0M
Treasury Stock	(1.0B)	(1.3B)	(1.9B)	(2.4B)	(2.2B)	(2.1B)
Net Tangible Assets	2.9B	3.4B	4.3B	4.4B	5.0B	5.3B
Capital Surpluse	1.6B	1.4B	1.7B	2.0B	2.3B	1.2B

Pair Trading with Edwards Lifesciences

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Edwards Lifesciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Edwards Lifesciences will appreciate offsetting losses from the drop in the long position's value.

Moving together with Edwards Stock

0.66

HQY

HealthEquity Financial Report 3rd of June 2024

Pair Corr

Moving against Edwards Stock

0.8	SINT	SINTX Technologies	Pair Corr
0.68	RSLS	ReShape Lifesciences	Pair Corr
0.63	BBLG	Bone Biologics Corp Financial Report 20th of May 2024	Pair Corr
0.63	CMAX	CareMax Trending	Pair Corr
0.56	HCAT	Health Catalyst Upward Rally	Pair Corr

The ability to find closely correlated positions to Edwards Lifesciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Edwards Lifesciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Edwards Lifesciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Edwards Lifesciences Corp to buy it.

The correlation of Edwards Lifesciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Edwards Lifesciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Edwards Lifesciences Corp moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Edwards Lifesciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Edwards Lifesciences Corp is a strong investment it is important to analyze Edwards Lifesciences' competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Edwards Lifesciences' future performance. For an informed investment choice regarding Edwards Stock, refer to the following important reports:

How To Invest In Edwards

Details

Is Edwards Stock a good investment?

Details

What is Edwards Lifesciences' Net Worth?

Details

Largest Health Care Equipment & Supplies Companies

View

Largest Health Care Equipment & Services Companies

View

Check out Edwards Lifesciences Valuation and Edwards Lifesciences Correlation analysis.

You can also try the Stocks Directory module to find actively traded stocks across global markets.

Complementary Tools for Edwards Stock analysis

When running Edwards Lifesciences' price analysis, check to measure Edwards Lifesciences' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Edwards Lifesciences is operating at the current time. Most of Edwards Lifesciences' value examination focuses on studying past and present price action to predict the probability of Edwards Lifesciences' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Edwards Lifesciences' price. Additionally, you may evaluate how the addition of Edwards Lifesciences to your portfolios can decrease your overall portfolio volatility.

	Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites
	Fundamental Analysis View fundamental data based on most recent published financial statements
	Technical Analysis Check basic technical indicators and analysis based on most latest market data
	Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
	Funds Screener Find actively-traded funds from around the world traded on over 30 global exchanges
	Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios
	Headlines Timeline Stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity
	Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities
	Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins
	Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance

Is Edwards Lifesciences' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Edwards Lifesciences. If investors know Edwards will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Edwards Lifesciences listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.06)

Earnings Share

2.3

Revenue Per Share

9.897

Quarterly Revenue Growth

0.138

Return On Assets

0.1225

The market value of Edwards Lifesciences Corp is measured differently than its book value, which is the value of Edwards that is recorded on the company's balance sheet. Investors also form their own opinion of Edwards Lifesciences' value that differs from its market value or its book value, called intrinsic value, which is Edwards Lifesciences' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Edwards Lifesciences' market value can be influenced by many factors that don't directly affect Edwards Lifesciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Edwards Lifesciences' value and its price as these two are different measures arrived at by different means. Investors typically determine if Edwards Lifesciences is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Edwards Lifesciences' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Edwards Balance Sheet Analysis From 2010 to 2024

Edwards Lifesciences fundamental ratios Correlations

Edwards Lifesciences Account Relationship Matchups

High Positive Relationship

High Negative Relationship

Edwards Lifesciences fundamental ratios Accounts

Pair Trading with Edwards Lifesciences

Moving together with Edwards Stock

Moving against Edwards Stock

Complementary Tools for Edwards Stock analysis

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY

Total Stockholder Equity	+ 0.99	Total Assets
Non Current Assets Total	+ 0.99	Total Assets
Property Plant And Equipment Net	+ 0.99	Total Stockholder Equity
Other Current Assets	+ 0.98	Total Assets
Non Current Assets Total	+ 0.98	Total Stockholder Equity
Non Current Assets Total	+ 0.98	Property Plant And Equipment Net

Total Current Assets	- 0.93	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.91	Total Assets
Inventory	- 0.9	Common Stock Shares Outstanding
Common Stock Shares Outstanding	- 0.9	Total Stockholder Equity
Other Current Assets	- 0.89	Common Stock Shares Outstanding
Property Plant And Equipment Gross	- 0.88	Common Stock Shares Outstanding